Search - tctmd.com

Displaying 141 - 160 of 278

Sort: Relevancy | Date

News Daily News

IV Alteplase No Help for Minor, Nondisabling Strokes in PRISMS Trial

Todd Neale

July 11, 2018

News Daily News

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

L.A. McKeown

July 10, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Daily News

ICD Use Curbed at Hospitals After US Department of Justice Scrutiny

Caitlin E. Cox

July 05, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2018

Shelley Wood

July 02, 2018

News Daily News

New Estimates of Bleeding Risks May Help CVD Prevention

Todd Neale

June 27, 2018

News Daily News

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Yael L. Maxwell

June 25, 2018

Presentation The Structural Heart Disease Summit 2018

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

Presenter: John D. Carroll, Brij Maini, Lars Sondergaard

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Rajan Gadhia

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Stephan Windecker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Presenter: Allan Schwartz, Stephan Windecker, Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

Presenter: Ariel Finkelstein

June 21, 2018

News Daily News

Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia

L.A. McKeown

June 13, 2018

News Daily News

Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors

Michael O'Riordan

June 13, 2018

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

L.A. McKeown

June 12, 2018

News Daily News

Erectile Dysfunction Is an Independent Predictor of Cardiovascular Events

Shelley Wood

June 12, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

Advertisement

IV Alteplase No Help for Minor, Nondisabling Strokes in PRISMS Trial

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

ICD Use Curbed at Hospitals After US Department of Justice Scrutiny

TCTMD’s Top 10 Most Popular Stories for June 2018

New Estimates of Bleeding Risks May Help CVD Prevention

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia

Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

Erectile Dysfunction Is an Independent Predictor of Cardiovascular Events

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content